If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTransense Regulatory News (TRT)

Share Price Information for Transense (TRT)

Share Price is delayed by 15 minutes
Get Live Data
48.50    0.00 (0.00%)
Bid:
48.00
Ask:
49.00
Spread: 1.00 (2.083%)
Market Cap: £7.38m
TRT Live PriceLast checked at - London Stock Exchange

Intraday Transense Share Chart

Board Changes

Today 07:00

RNS Number : 2289L
Transense Technologies PLC
07 July 2026
 

7 July 2026

Transense Technologies plc

("Transense" or the "Company")

Board Changes

Retirement of Chief Financial Officer and Appointment of Finance Director (designate)

Transense Technologies plc (AIM: TRT), the provider of specialist sensor technology and measurement solutions, announces that Melvyn Segal has informed the Board of his intention to retire from the role of Chief Financial Officer ("CFO") and Company Secretary with effect from the Company's Annual General Meeting (AGM) in November 2026. The Board also announces the appointment of Richard Michael Pearce ACA as Finance Director with effect from 1 September 2026.

Melvyn will remain with the Company in an executive capacity for a handover period until the AGM, and will subsequently remain on the Board as a non-executive director for a further year. The Board would like to thank Melvyn for his significant contribution to Transense over many years, during which the Company and its prospects have been transformed.

Richard brings over twenty years of financial, commercial and listed company experience to Transense. Since qualifying as a Chartered Accountant with Ernst & Young in 1999, he has held senior finance roles at GE Healthcare and TD Williamson, and most recently as Finance Director at Lombard Medical where he oversaw a scale-up in revenues from £6m to £25m per annum since 2018. He will initially work alongside Melvyn in a non-board role as Finance Director, with progression to the Board leading the Group's finance function when Melvyn's steps down as CFO in November 2026.

The Board welcomes Richard to his new role and we look forward to his contribution to delivery of the future growth strategy.

For further information please visit www.transense.com or contact:

Transense Technologies plc

Nigel Rogers (Executive Chairman)

Ryan Maughan (Managing Director)

Melvyn Segal (Chief Financial Officer)

Via Investor Relations

(see below)

Cavendish Capital Market Limited (Nominated Adviser and Broker)

Adrian Hadden / Callum Davidson (Corporate Finance)

Jasper Berry (Sales)

0207 220 0500

Investor Relations

Anice McNamee

Tel: +44 (0)1869 238380

Investor.relations@transense.co.uk

Notes to Editors:

Transense is headquartered in Oxfordshire, UK and its shares are traded on AIM, a market operated by the London Stock Exchange (AIM: TRT). The Company develops and supplies advanced sensor technology and measurement solutions used by some of the world's leading companies to improve performance, efficiency, and safety in demanding, mission critical applications. Transense currently operates through two active business segments:

· SAWsense - designs, supplies and licences advanced sensor solutions based on proven, patent protected Surface Acoustic Wave (SAW) technology to world leading companies in aerospace, automotive, and industrial machinery (including robotics), enabling improved efficiency and performance of their products. Key customers include GE Aerospace, Parker Meggitt, McLaren Applied, Airbus and several other confidential Tier One automotive, aerospace and industrial machinery suppliers.

 

· Translogik - develops smart, connected commercial vehicle tyre inspection equipment to many of the world's leading tyre suppliers, fleet operators and service centres. Enabling accurate measurement and digital capture of safety-critical tyre condition data, used to reduce operating costs, improve safety and provide audit records for regulatory compliance. Key customers include Bridgestone, Goodyear, Continental and Prometeon (Pirelli), and leading independent providers of vehicle fleet maintenance management software.

 In addition, Transense earns residual royalty income from Bridgestone iTrack - a tyre monitoring system for off-highway vehicles that was developed by Translogik. The associated sales, support and development infrastructure were sold to Bridgestone Corporation, the world's largest tyre producer, in June 2020, and the intellectual property was licensed exclusively to Bridgestone under a ten-year deal expiring in 2030.

Find out more at: https://www.transense.com/

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAAKABQCBKDDOK
Date   Source Headline
26th Oct 20127:00 amRNSChange of Name of Nominated Adviser
26th Oct 20127:00 amRNSAGM Statement
3rd Oct 20127:00 amRNSFinal Results and Notice of AGM
17th Sep 20127:00 amRNSExercise of Warrants
6th Sep 201212:30 pmRNSHolding(s) in Company
3rd Sep 20127:00 amRNSIntelliSAW Commercial Update
31st Aug 20123:00 pmRNSTotal Voting Rights
30th Aug 201211:07 amRNSHolding(s) in Company
28th Aug 20127:00 amRNSiTrack order from AutoRFID Solutions
3rd Aug 20129:46 amRNSAward of Options
2nd Aug 20124:45 pmRNSExercise of Warrants
2nd Aug 20124:13 pmRNSInitial Order from Anglo American
1st Aug 20125:45 pmRNSHolding(s) in Company
1st Aug 201211:28 amRNSResult of General Meeting and Placing
31st Jul 20123:40 pmRNSTotal Voting Rights
18th Jul 201211:20 amRNSExercise of Warrants
16th Jul 20127:00 amRNSStrategic Distribution Agreement in Peru
10th Jul 20129:35 amRNSExercise of Warrants
9th Jul 201211:08 amRNSHolding(s) in Company
6th Jul 20123:30 pmRNSPosting of Circular
4th Jul 201211:23 amRNSExercise of Warrants
2nd Jul 20121:00 pmRNSReplacement re Total Voting Rights
29th Jun 20124:20 pmRNSInterim Results
29th Jun 20124:20 pmRNSPlacing to raise £1.756 million
29th Jun 20127:00 amRNSTotal Voting Rights
25th Jun 20127:00 amRNSMichelin uses iProbe in new 'communicating' tyres
22nd Jun 201211:05 amRNSTranslogik further order from EDP
15th Jun 201210:47 amRNSStrategic Distribution Agreement in Saudi Arabia
12th Jun 20127:00 amRNSStrategic Distribution Agreement in Malaysia
11th Jun 20127:00 amRNSAppointment of Group Executive Finance Director
6th Jun 20124:41 pmRNSExercise of Warrants
31st May 201210:53 amRNSTotal Voting Rights
31st May 20127:00 amRNSiTrack success in southern Africa
29th May 20127:00 amRNSChinese partner places order worth over USD 500k
17th May 20127:00 amRNSFirst IntelliSAW customer in India
1st May 20122:23 pmRNSExercise of Warrants
11th Apr 20127:00 amRNSIntelliSAW confirmed orders of USD 550k
4th Apr 20127:00 amRNSBridgestone Brazil Update
23rd Mar 20127:00 amRNSExclusive Distribution Agreement for India
5th Mar 20124:30 pmRNSHolding(s) in Company
28th Feb 20127:00 amRNSIntelliSAW US Representative Agreement
23rd Feb 20127:00 amRNSTranslogik order from EDP for Michelin Euromaster
6th Feb 20127:00 amRNSBridgestone Brazil order for iProbe
3rd Feb 201212:46 pmRNSReplacement - Change of Adviser
1st Feb 20127:00 amRNSChange of Adviser
17th Jan 20127:00 amRNSIntelliSAW Volume Production Shipments
30th Dec 20117:00 amRNSTotal Voting Rights
28th Dec 201112:25 pmRNSHolding(s) in Company
23rd Dec 20119:01 amRNSChange of status to executive director and award
21st Dec 20112:00 pmRNSResult of Fundraising

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.